Binding of high-avidity anti-β2-glycoprotein I antibodies

被引:14
作者
Cucnik, S
Kveder, T
Rozman, B
Bozic, B
机构
[1] Univ Ljubljana, Med Ctr, Dept Rheumatol, Ljubljana 1000, Slovenia
[2] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia
关键词
anti-beta 2-glycoprotein I antibodies; Fab fragments; avidity; affinity; antiphospholipid syndrome; systemic lupus erythematosus;
D O I
10.1093/rheumatology/keh349
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. We studied the influence of different binding conditions on the interaction between high- or low-avidity IgG anti-beta(2)-glycoprotein I antibodies (anti-beta(2)-GPI) and beta(2)-GPI, which was either free in solution or bound to microtitre plates or nitrocellulose membranes. Methods. Sera from 30 patients with antiphospholipid syndrome and/or systemic lupus erythematosus were selected on the basis of anti-beta(2)-GPI positivity. Avidity of IgG anti-beta(2)-GPI was determined by chaotropic ELISA, using increased NaCl concentration during the antibody binding. Immunodetection on nitrocellulose membrane followed reducing or non-reducing sodium dodecyl sulphate-polyacrylamide gel electrophoresis (PAGE) of beta(2)-GPI. In converted, non-reducing PAGE, the preparation with high-affinity Fab fragments (obtained by papain digestion) was subjected to electrophoresis, while purified beta(2)-GPI was used as the sample in immunodetection. Results. Anti-beta(2)-GPI antibodies of high, low or heterogeneous (low and high) avidity were found in 5/30, 9/30 and 16/30 sera, respectively. The density of beta(2)-GPI, which was 20-30 times higher on the nitrocellulose membrane than on the surface of ELISA plates, was not sufficient for the recognition of the antigen by anti-beta(2)-GPI: 2/5 high-avidity samples reacted only with non-reduced beta(2)-GPI, 3/9 low-avidity samples recognized only denatured and reduced beta(2)-GPI, and 1/16 samples with heterogeneous-avidity antibodies reacted with reduced and non-reduced beta(2)-GPI. Conclusions. Our results suggest that neither high density of the antigen nor high avidity of the antibodies (or Fab fragments) alone was sufficient for the binding of anti-beta(2)-GPI to beta(2)-GPI. Some conformational modifications and, consequently, exposed neo-epitopes are required for the recognition of beta(2)-GPI by polyclonal anti-beta(2)-GPI antibodies.
引用
收藏
页码:1353 / 1356
页数:4
相关论文
共 21 条
[1]  
Arnout J, 1998, THROMB HAEMOSTASIS, V79, P79
[2]  
Chamley LW, 1999, CLIN EXP IMMUNOL, V115, P571
[3]   Anti-β2-glycoprotein I ELISA:: Methodology, determination of cut-off values in 434 healthy Caucasians and evaluation of monoclonal antibodies as possible international standards [J].
Cucnik, S ;
Ambrozic, A ;
Bozic, B ;
Skitek, M ;
Kveder, T .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2000, 38 (08) :777-783
[4]  
CUCNIK S, 2004, IN PRESS ANN RHEUM
[5]   ANTICARDIOLIPIN ANTIBODIES (ACA) DIRECTED NOT TO CARDIOLIPIN BUT TO A PLASMA-PROTEIN COFACTOR [J].
GALLI, M ;
COMFURIUS, P ;
MAASSEN, C ;
HEMKER, HC ;
DEBAETS, MH ;
VANBREDAVRIESMAN, PJC ;
BARBUI, T ;
ZWAAL, RFA ;
BEVERS, EM .
LANCET, 1990, 335 (8705) :1544-1547
[6]   Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [J].
Hochberg, MC .
ARTHRITIS AND RHEUMATISM, 1997, 40 (09) :1725-1725
[7]   ROLE OF BETA(2)-GLYCOPROTEIN-I AND ANTIPHOSPHOLIPID ANTIBODIES IN ACTIVATION OF PROTEIN-C IN-VITRO [J].
KEELING, DM ;
WILSON, AJG ;
MACKIE, IJ ;
ISENBERG, DA ;
MACHIN, SJ .
JOURNAL OF CLINICAL PATHOLOGY, 1993, 46 (10) :908-911
[8]   ANTICARDIOLIPIN ANTIBODIES RECOGNIZE BETA(2)-GLYCOPROTEIN-I STRUCTURE ALTERED BY INTERACTING WITH AN OXYGEN MODIFIED SOLID-PHASE SURFACE [J].
MATSUURA, E ;
IGARASHI, Y ;
YASUDA, T ;
TRIPLETT, DA ;
KOIKE, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (02) :457-462
[9]   ANTICARDIOLIPIN COFACTOR(S) AND DIFFERENTIAL-DIAGNOSIS OF AUTOIMMUNE-DISEASE [J].
MATSUURA, E ;
IGARASHI, Y ;
FUJIMOTO, M ;
ICHIKAWA, K ;
KOIKE, T .
LANCET, 1990, 336 (8708) :177-178
[10]   ANTIPHOSPHOLIPID ANTIBODIES ARE DIRECTED AGAINST A COMPLEX ANTIGEN THAT INCLUDES A LIPID-BINDING INHIBITOR OF COAGULATION - BETA-2-GLYCOPROTEIN-I (APOLIPOPROTEIN-H) [J].
MCNEIL, HP ;
SIMPSON, RJ ;
CHESTERMAN, CN ;
KRILIS, SA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (11) :4120-4124